Orphan nuclear receptor DAX-1 in human endometrium and its disorders

Cancer Science

Volumn 96, Issue 10, 2005, Pages 645-652

  Saito, Sumika ^a   Ito, Kiyoshi ^a   Suzuki, Takashi ^a   Utsunomiya, Hiroki ^a   Akahira, Jun Ichi ^a   Sugihashi, Youko ^a   Niikura, Hitoshi ^a   Okamura, Kunihiro ^a   Yaegashi, Nobuo ^a   Sasano, Hironobu ^a  

^a TOHOKU UNIVERSITY GRADUATE SCHOOL OF MEDICINE   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

AROMATASE; ESTROGEN RECEPTOR ALPHA; MESSENGER RNA; NUCLEAR RECEPTOR DAX 1; STEROIDOGENIC FACTOR 1;

ARTICLE; CANCER GRADING; CANCER GROWTH; CANCER INHIBITION; CANCER STAGING; CONTROLLED STUDY; CORRELATION ANALYSIS; ENDOMETRIUM CANCER; ENDOMETRIUM CARCINOMA; ENDOMETRIUM HYPERPLASIA; ESTROGEN ACTIVITY; FEMALE; HISTOPATHOLOGY; HUMAN; HUMAN CELL; HUMAN CELL CULTURE; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; IMMUNOREACTIVITY; MAJOR CLINICAL STUDY; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN FUNCTION; PROTEIN LOCALIZATION; QUANTITATIVE ANALYSIS; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; STEROIDOGENESIS; STROMA CELL;

ADRENAL GLANDS; AROMATASE; CARCINOMA; CELL LINE; DNA-BINDING PROTEINS; ENDOMETRIAL HYPERPLASIA; ENDOMETRIAL NEOPLASMS; ENDOMETRIUM; ESTROGEN RECEPTOR ALPHA; ESTROGEN RECEPTOR BETA; FEMALE; HELA CELLS; HUMANS; IMMUNOHISTOCHEMISTRY; RECEPTORS, RETINOIC ACID; REPRESSOR PROTEINS; RNA, MESSENGER;

EID: 28444470482     PISSN: 13479032     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1349-7006.2005.00101.x     Document Type: Article

References (48)

1. Parker SL, Tong T, Bolden S, Wingo PA. Cancer statistics. CA Cancer J Clin 1996; 46: 25-7.
2. Parazzini F, La Vecchia C, Bocciolone L, Francheschi S. The epidemiology of endometrial cancer. Gynecol Oncol 1991; 41: 1-16.
3. Silverberg SG, Mullen D, Faraci JA et al. Clinical-pathologic comparison of cases in postmenopausal women receiving exogenous estrogens. Cancer 1980; 45: 3018-26.
4. Kelsey JL. A case control study of cancer of the endometrium. Am J Epidemiol 1982; 16: 333-42.
5. Lippman ME, Swain SA. Endocrine-responsive cancers of humans. In: Wilson JD, Foster DW, eds. Williams Textbook of Endocrinology. Philadelphia: Saunders, 1992; 1577-97.
6. Zanaria E, Muscatelli F, Bardoni B et al. An unusual member of the nuclear hormone receptor superfamily responsible for X-linked adrenal hypoplasia congenita. Nature 1994; 372: 635-45.
7. Swain A, Zanaria E, Hacker A, Lovell-Badge R, Camerino G. Mouse Dax1 expression is consistent with a role in sex determination as well as in adrenal and hypothalamus function. Nat Genet 1996; 12: 404-9.
8. Tamai KT, Monaco L, Alastalo TP, Lalli E, Prvinen M, Sassone-Corsi P. Hormonal and developmental regulation of DAX-1 expression in Sertoli cells. Mol Endocrinol 1996; 10: 1561-9.
9. Ikeda Y, Swain A, Weber TJ et al. Steroidogenic factor 1 and DAX-1 colocalization in multiple cell lineages: potential kinks in endocrine development. Mol Endocrinol 1996; 10: 1261-72.
10. Lalli E, Melner MH, Stocco DM, Sassone-Corsi P. DAX-1 blocks steroid production at multiple levels. Endocrinology 1998; 139: 4237-43.
11. Zazopoulos E, Lalli E, Stocco DM, Sassone-Corsi P. DNA binding and transcriptional repression by DAX-1 blocks steroidogenesis. Nature 1997; 390: 311-5.
12. Sugawara T, Lin D, Hoolt J et al. Structure of the human steroidogenic acute regulatory protein (StAR) gene: StAR stimulates mitochondrial cholesterol 27 hydroxylase activity. Biochemistry 1995; 34: 12506-12.
13. Stocco DM, Clark BJ. Regulation of acute production of steroid in steroidogenic tissue. Endocr Rev 1996; 17: 221-44.
14. Parker KL, Schimmer BP. Steroidogenic factor 1: a key determinant of endocrine development and function. Endocr Rev 1997; 18: 361-77.
15. Takayama K, Sasano H, Fukuya T et al. Immunohistochemical localization of Ad4-binding protein with correlation to steroidogenic enzyme expression in cycling human ovaries and sex cord stromal tumors. J Clin Endocrinol Metab 1995; 80: 2815-21.
16. Crawford PA, Dorn C, Sadovsky Y, Milbrandt J. Nuclear receptor DAX-1 recruits nuclear receptor corepressor N-CoR to steroidogenic factor 1. Mol Cell Biol 1998; 18: 2949-56.
17. Hanley NA, Rainey WE, Wilson DI, Ball SG, Parker KL. Expression profiles of SF-1, DAX1, and CYP17 in the human fetal adrenal gland: potential interactions in gene regulation. Mol Endocrinol 2001; 15: 57-68.
18. Wang ZJ, Jeffs B, Ito M et al. Aromatase (Cyp19) expression is upregulated by targeted disruption of Dax1. Proc Natl Acad Sci USA 2001; 98: 7988-93.
19. Gurates B, Sebastian S, Yang S et al. WT1 and DAX-1 inhibit aromatase P450 expression in human endometrial and endometriotic stromal cells. J Clin Endocrinol Metab 2002; 87: 4369-77.
20. Lalli E, Ohe K, Hindelang C, Sassone-Corsi P. Orphan receptor DAX-1 is a shuttling RNA binding protein associated with polyribosomes via mRNA. Mol Cell Biol 2000; 20: 4910-21.
21. Zhang H, Thomsen JS, Johansson L, Gustafsson JA, Treuter E. DAX-1 functions as an LXXLL-containing corepressor for activated estrogen receptors. J Biol Chem 2000; 275: 39855-9.
22. Creasman WT. FIGO Stages: 1988 revision. Gynecol Oncol 1989; 35: 125-7.
23. Patel MV, Mckay IA, Burrin JM. Transcriptional regulators of steroidogenesis, DAX-1 and SF-1, are expressed in human skin. J Invest Dermatol 2001; 117: 1559-65.
24. Aylwin SJ, Welch JP, Davey CL et al. The relationship between steroidogenic factor 1 and DAX-1 expression and in vitro gonadotropin secretion in human pituitary adenomas. J Clin Endocrinol Metab 2001; 86: 2476-83.
25. Holter E, Kotaja N, Makela S et al. Inhibition of androgen receptor (AR) function by the reproductive orphan nuclear receptor DAX-1. Mol Endocrinol 2002; 16: 515-28.
26. Agoulnik IU, Krause WC, Bingman WE 3rd et al. Repressors of androgen and progesterone receptor action. J Biol Chem 2003; 278: 31136-48.
27. Sato Y, Suzuki T, Hidaka K et al. Immuno-localizaion of nuclear transcription factor, DAX-1 and COUP-TF in the normal human ovary: correlation with Ad4BP/SF-1 immuno-localization during the menstrual cycle. J Clin Endocrinol Metab 2002; 87: 4369-77.
28. Manar A-E, Akahira J, Moriya T, Suzuki T, Yaegashi N, Sasano H. Nuclear receptor DAX-1 in human common epithelial ovarian carcinoma: An independent prognostic factor of clinical outcome. Cancer Sci 2003; 94: 980-5.
29. Honda S, Morohashi K, Nomura M, Takeya H, Kitajima M, Omura T. Ad4BP regulating steroidogenic P-450 gene is a member of steroid hormone receptor superfamily. J Biol Chem 1993; 268: 7494-502.
30. Suzuki T, Sasano H, Kimura N et al. Immunohistochemical distribution of progesterone, androgen and oestrogen receptors in the human ovary during the menstrual cycle: relationship to expression of steroidogenic enzymes. Hum Reprod 1994; 9: 1589-95.
31. Sasano H, Shizawa S, Suzuki T et al. Ad4BP in the human adrenal cortex and its disorder. J Clin Endocrinol Metab 1995; 80: 2378-80.
32. Layfield LJ, Gupta D, Mooney EE. Assessment of tissue estrogen and progesterone receptor levels: a survey of current practice, techniques, and quantitation methods. Breast J 2000; 6: 189-96.
33. Wittwer CT, Ririe KM, Andrew RV, David DA, Gundry RA, Balis UJ. The LightCycler: a microvolume multisame fluorimeter with rapid temperature control. Biotechniques 1997; 22: 176-81.
34. Read SJ. Recovery efficiencies on nuclei acid extraction kits as measured by quantitative LightCycler PCR. Mol Pathol 2001; 54: 86-90.
35. Dumoulin FL, Nischalke HD, Leifeld L et al. Semi-quantification of human C-C chemokine mRNAs with reverse transcription/real time PCR using multi-specific standards. J Immunol Methods 2000; 241: 109-19.
36. Saruta M, Takahashi K, Suzuki T, Torii A, Kawakami M, Sasano H. Ucrocorin 1 in colonic mucosa in patients with ulcerative colitis. J Clin Endocrinol Metab 2004; 89: 5352-61.
37. Watanabe K, Sasano H, Harada N et al. Aromatase in human endometrial carcinoma and hyperplasia: Immunohistochemical in situ hybridization, and biochemical studies. Am J Pathol 1995; 146: 491-500.
38. Utsunomiya H, Suzuki T, Kaneko C et al. The analyses of 17β-hydroxysteroid dehydrogenase isozyme in human endometrial hyperplasia and carcinoma. J Clin Endocrinol Metab 2001; 86: 3436-43.
39. Jongen VH, Sluijmer AV, Heineman MJ. The postmenopausal ovary as an androgen-producing gland; hypothesis on the etiology of endometrial cancer. Maturitas 2002; 43: 77-85.
40. Utsunomiya H, Ito K, Suzuki T et al. Steroid sulfatase and estrogen sulfotransferase in human endometrial carcinoma. Clin Cancer Res 2004; 10: 5850-6.
41. Hinshelwood MM, Repa JJ, Shelton JM, Richardson JA, Mangelsdorf DJ, Mendelson CR. Expression of LRH-1 and SF-1 in the mouse ovary: localization in different cell types correlates with differing function. Mol Cell Endocrinol 2003; 207: 39-45.
42. Clyne CD, Speed CJ, Zhou J, Simpson ER. Liver Receptor Homologue-1 (LRH-1) regulates expression of aromatase in preadipocytes. J Biol Chem 2002; 277: 20591-7.
43. Matsuzaki S, Fukaya T, Suzuki T, Murakami T, Sasano H, Yajima A. Oestrogen receptor γ and β mRNA expression in human endometrium throughout the menstrual cycle. Mol Human Reprod 1999; 5: 559-64.
44. Baak JPA, Wisse-Brekelmans ECM, Fleege JC, van der Putten HWHM, Bezemer PD. Assessment of the risk of endometrial cancer in hyperplasia by means of morphological and morphometrical features. Path Res Pract 1992; 188: 856-9.
45. Kurman RJ, Kaminski PF, Norris HJ. The behavior of endometrial hyperplasia. A long-term study of 'untreated' hyperplasia in 170 patients. Cancer 1985; 56: 403-12.
46. Maxwell GL, Risinger JI, Gumbs C et al. Mutation of the PTEN tumor suppressor gene in endometrial hyperplasia. Cancer Res 1998; 58: 2500-3.
47. Sasaki H, Nishii H, Takahashi H et al. Mutation of the Ki-ras protooncogene in human endometrial hyperplasia and carcinoma. Cancer Res 1993; 53: 1906-10.
48. Ngan ES, Hashimoto Y, Ma ZQ, Tsai MJ, Tsai SY. Overexpression of Cdc25B, an androgen receptor coactivator, in prostate cancer. Oncogene 2003; 22: 734-9.